Delivery Order SPE2DB22D1103-SPE2DB25FTST1
- Not listed
- The Defense Logistics Agency awarded a $16,252.69 delivery order to AmerisourceBergen Drug Corp for DUPIXENT 300 mg/2 mL pens on August 22, 2025, with an ultimate completion date of August 25, 2025. This non-set-aside, firm fixed price contract represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The award is performed from the vendor's Conshohocken, Pennsylvania location, the company's corporate headquarters....
- The Defense Logistics Agency awarded a $5,001.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp for DUPIXENT 300 mg/2 mL pens on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-set-aside contract represents a delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for DUPIXENT 300 mg/2 ml pen injectors, valued at $6,777.99, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a continuation of the company's ongoing pharmaceutical supply relationship with the federal government. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for DUPIXENT 300 MG/2 ML pen injections with a ceiling value of $4,147.68 under a firm fixed price contract type. The award was made on September 3, 2025, with an ultimate completion date of September 4, 2025, with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order represents a child...
- The Defense Logistics Agency awarded a $3,418.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for supply of DUPIXENT 200 mg/1.14 ml pen injectors, with an ultimate completion date of August 12, 2025. This non-set-aside award represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA Troop Support Medical. The product will be performed at the contractor's location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $7,883.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of DUPIXENT 300 mg/2 mL pens (2 mL units). This contract is non-set-aside and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The point of performance is located in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a delivery order valued at $48,006.54 to AmerisourceBergen Drug Corp for DUPIXENT 300 mg/2 mL pens on August 14, 2025, with an ultimate completion date of August 15, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,298.32 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen (2 ml) on June 27, 2025, with an ultimate completion date of June 30, 2025. This competitive award (no set-aside used) carries firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $22,033.26 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pens, with an ultimate completion date of July 25, 2025. This competitive award uses firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle. The pharmaceutical product will be performed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $147,823.11 to AmerisourceBergen Drug Corp for DUPIXENT 300 MG/2 ML pens on September 8, 2025, with completion scheduled for September 9, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the prime contractor under its existing indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's distribution...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB25FTST1Delivery Order
The Defense Logistics Agency awarded a $6,049.03 delivery order to AmerisourceBergen Drug Corp for DUPIXENT 300 mg/2 mL pens (2 mL units) with a firm fixed price structure and an ultimate completion date of July 28, 2025. This non-set-aside contract was competitively awarded and represents a child order under AmerisourceBergen's broader pharmaceutical supply agreements with the federal government. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. This comprehensive pharmaceutical prime vendor contract enables AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies to support military healthcare systems globally, including the Defense Health Agency and U.S. Coast Guard. The current award for DUPIXENT, a specialty pharmaceutical treatment, exemplifies the type of specialized medications distributed through this contract vehicle to meet Department of Defense medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 7/25/25 |